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AbstrACt
Introduction Corneal opacity is a leading cause of 
blindness worldwide. In resource-limited settings, 
untreated traumatic corneal abrasions may result in 
infection and ultimately, opacity. Although antimicrobial 
treatment of corneal ulcers may successfully cure 
infections, the scarring that accompanies the resolution of 
infection can still result in visual impairment. Prevention 
may be the optimal approach for reducing corneal 
blindness. Studies have employed community health 
workers to provide prompt administration of antimicrobials 
after corneal abrasions to prevent infections, but these 
studies were not designed to determine the effectiveness 
of such a programme.
Methods and analysis The Village-Integrated Eye 
Worker trial (VIEW) is a cluster-randomised trial designed 
to assess the effectiveness of a community health 
worker intervention to prevent corneal ulcers. Twenty-
four Village Development Committees (VDCs) in Nepal 
were randomised to receive a corneal ulcer prevention 
programme or to no intervention. Female Community 
Health Volunteers (FCHVs) in intervention VDCs are trained 
to diagnose corneal abrasions, provide antimicrobials and 
to refer participants when needed. An annual census is 
conducted over 3 years in all study VDCs to assess the 
incidence of corneal ulceration via corneal photography 
(primary outcome). Masked outcome assessors grade 
corneal photographs to determine the presence or absence 
of incident corneal opacities. The primary analysis is 
negative binomial regression to compare the incidence of 
corneal ulceration by study arm.
Ethics and dissemination The University of California 
San Francisco Committee on Human Research, Nepal 
Netra Jyoti Sangh and the Nepal Health Research Council 
have given ethical approval for the trial. The results of this 
trial will be presented at local and international meetings 
and submitted to peer-reviewed journals for publication.
trial registration number NCT01969786; Pre-results.
IntroduCtIon 
Prevention may be the best option for 
reducing the burden of corneal blindness 
caused by corneal ulcers. Corneal opacity is 
the fourth leading cause of blindness world-
wide, with a disproportionate burden borne 
by low-income and middle-income coun-
tries.1–3 In such settings, corneal abrasions 
that occur as a result of agricultural trauma 
often go untreated, increasing the chances 
of a bacterial or fungal corneal ulcer and 
subsequent opacity.4–8 Even successful anti-
microbial treatment often leaves a patient 
with visual impairment because of the 
associated immune response and resultant 
corneal scar.9–11 Delays in presentation and 
initiation of antimicrobial therapy result in 
worse clinical outcomes, including severe 
visual impairment and corneal perfo-
ration.12–15 Indeed, the ultimate visual 
outcome depends less on the specific anti-
microbial or anti-inflammatory agent used, 
and far more on the visual acuity at the time 
antimicrobial therapy is started.9 16 Reducing 
the delay in starting antimicrobial therapy 
strengths and limitations of this study
 ► The  Village-Integrated Eye Worker  Trial is the first 
randomised controlled trial designed to determine 
the effectiveness of a community health worker in-
tervention to prevent corneal ulcers.
 ► The large simple trial design allows detection of a 
modest intervention effect for a rare outcome.
 ► Given the nature of the intervention, the study par-
ticipants and field staff could not be masked.
 ► The use of corneal photography allows for a masked 
comparison of the primary outcome.
 ► Cluster  randomisation reduces the risk of contam-
ination, although contamination of randomisation 
units is still possible in this design. The extent 
of contamination will be measured with process 
indicators.
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following a corneal abrasion could prevent infections 
from developing, and thus could be the best way to 
reduce corneal opacity-related vision loss in resource-
poor settings.
A promising approach for corneal ulcer prevention 
is the use of community health workers to diagnose 
corneal abrasions and provide prompt administration of 
antimicrobials. Community-level interventions have the 
potential to increase service uptake in settings with poor 
access to the healthcare system and may reduce delays in 
seeking treatment.17 Community-based approaches are 
feasible for eye diseases, with notable successes demon-
strated by mass drug administrations for onchocerciasis 
and trachoma.18–22 Several studies have found low rates of 
infectious keratitis after implementing community health 
worker programmes for prophylaxis of corneal abra-
sions.23–26 However, these studies were unable to assess the 
causal impact of the programmes, since all participants 
were included in the interventions. A cluster-randomised 
trial would provide the strongest form of evidence for the 
effectiveness of a community health worker programme 
for corneal ulcer prevention.
Designing a randomised trial to determine the effec-
tiveness of a corneal ulcer prevention programme is chal-
lenging. Corneal ulceration is a relatively rare outcome, 
with estimates ranging from 11 cases per 100 000 person-
years in Minnesota to 799 cases per 100 000 person-
years in Nepal.23 24 27–30 A very large sample size would 
be needed to enrol enough cases to detect an effect. 
Furthermore, corneal ulcer detection is difficult. Previous 
studies have relied on programme referrals, but in a trial 
setting with a control group, this approach is prone to 
bias.23–26 Clinic-based case finding would likely underes-
timate the true number of corneal ulcers in settings with 
poor access to healthcare. This approach could also result 
in bias between the groups, with a paradoxically higher 
number of patients in the intervention group due to 
increased attention and referrals. In addition, a successful 
programme would require publicity and education, which 
might be difficult to administer in a randomised fashion 
to a public at risk for a disease but not yet afflicted and 
may result in contamination.
In the present report, we describe the methods of a 
cluster-randomised trial that uses a large simple trial 
design to overcome these challenges.31 The Village-Inte-
grated Eye Worker (VIEW) trial is a cluster-randomised 
trial designed to determine the effectiveness of a commu-
nity health worker-based intervention to prevent corneal 
ulcers. Community randomisation protects against the 
risk of contamination posed by an individual-randomised 
trial, increases feasibility of intervention delivery and is 
well suited for the nature of a corneal ulcer prevention 
intervention. A simple outcome (incidence of corneal 
ulceration), assessed identically within the intervention 
and control communities using electronic data capture 
and smartphone-based photography, allows a large 
sample size and sufficient statistical power to detect a 
modest treatment effect for a rare outcome.
MEthods And AnAlysIs
study overview
In the VIEW trial, Village Development Committees 
(VDCs) in rural and semi-urban Nepal were randomised 
in a 1:1 ratio to intervention or control. In communities 
randomised to the intervention, existing Female Commu-
nity Health Volunteers (FCHVs) are trained to diagnose 
corneal abrasions and provide antimicrobial ointments 
as prophylaxis. An active publicity campaign in inter-
vention communities encourages residents to present to 
the community health worker within 24 hours of ocular 
trauma. In control communities, existing FCHVs receive 
no additional training and no publicity campaign is 
conducted. No changes to existing eye healthcare services 
are otherwise made, and residents from both arms are 
free to seek care at any local healthcare facilities for 
eye complaints. Masked outcome assessors perform an 
annual census in both intervention and control commu-
nities over a 3-year period. Census workers photograph 
both corneas of all residents on enrolment into the study 
and at the fourth annual census, and at any intervening 
census in which a resident reports symptoms consistent 
with a corneal ulcer. Corneal photographs are later 
graded for corneal opacity by masked examiners. An over-
view of study procedures and study timeline is provided in 
table 1.
specific aims and outcomes
The specific aims of this trial are (1) to determine 
whether diagnosis and prophylaxis of corneal abrasions 
by community health workers will reduce the incidence of 
corneal ulceration in rural Nepal, (2) to assess the cost-ef-
fectiveness of the corneal ulcer prevention programme 
and (3) to estimate the true incidence of corneal ulcer-
ation in this population. We hypothesise that communi-
ties in which community health workers are available to 
provide diagnosis and prophylaxis for corneal abrasions 
will have a significantly lower incidence of corneal ulcer-
ation compared with communities without this service. 
The primary outcome (specific aim 1) is incident corneal 
opacity in an individual during the 3-year study period, as 
determined from corneal photography. ‘Incident corneal 
opacity’ is defined as the absence of photographic 
evidence of a corneal opacity at one census visit followed 
by the presence of photographic evidence of an opacity 
at a subsequent visit. Secondary outcomes include (1) the 
prevalence of visual impairment caused by corneal ulcer-
ation as assessed through clinical exams of residents with 
incident corneal opacities, (2) time from ocular trauma 
until presentation to the FCHV and (3) awareness of 
the intervention among the study population as assessed 
through an annual survey.
setting and eligibility
We are conducting this study in all communities from 24 
VDCs (government-defined administrative units) in the 
Chitwan and Nawalparasi districts of Nepal. VDC-level 
eligibility criteria include location within the catchment 
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area of the Bharatpur Eye Hospital and population of 
<15 000 per the 2001 government census. Of 112 VDCs 
in these districts, 24 meet these eligibility criteria and 
are included in the trial. Geographic separation was not 
considered in selection of eligible VDCs. All residents in 
study communities are offered enrolment in each annual 
census. A census worker visits each household in each 
village included in the study. At the baseline visit, verbal 
consent from each head of household was obtained for 
participation of all household members in the census 
visits. Data collection for the baseline visit began in 
January 2014.
randomisation and masking
After the baseline census, VDCs were randomised with 
stratification by district (Chitwan vs Nawalparasi) to 
receive the intervention or no intervention. Stratification 
is performed to minimise the chances of bias that could 
have occurred if the randomisation had been unbalanced 
between the two geographically distant sets of commu-
nities. The study biostatistician generated the random 
allocation sequence using R (R Foundation for Statistical 
Computing, Vienna, Austria). Allocation is concealed 
by enrolling all communities before randomisation and 
offering the intervention to all community members. 
Study staff from the Bharatpur Eye Hospital are respon-
sible for implementation of the randomisation sequence.
Due to the nature of the intervention, FCHVs in inter-
vention VDCs are not masked to treatment allocation. The 
District Chief Public Health Officers, who oversee FCHVs 
in both intervention and control VDCs, are informed of 
the study arms. Personnel who perform census activities 
are unaware of treatment allocation. In addition, all study 
personnel conducting photograph grading are masked 
to treatment allocation. These photograph graders 
are crucial to mask since they are assessing the primary 
outcome of the trial. The photograph graders are also the 
easiest to mask, since photographs can be displayed in a 
random order without identifying information.
Intervention
Female Community Health Volunteers
The FCHV programme was initiated by the govern-
ment of Nepal in 1988.32 The programme aims to link 
communities to healthcare and to provide communi-
ty-based services and health promotion.33 FCHVs are 
selected by their communities, live in the wards they 
serve and have experience implementing community 
Table 1 Timeline of major study procedures*
Time point Activity Description of activities
Month 0 Phase 0 census (baseline) In all 24 study VDCs, collect the following data:
 ► Demographics
 ► Ocular history screening (lifetime)
 ► Bilateral photography of all participants
Month 6 Randomisation Randomise 12 VDCs to receive intervention and 12 VDCs to receive no 
intervention
Intervention implementation In 12 intervention VDCs, train FCHVs to:
 ► Diagnose corneal abrasions
 ► Provide antimicrobial ointments for abrasions
 ► Refer when needed
Month 8 Intervention awareness survey In all 24 study VDCs, conduct a survey of a random sample of households to 
assess level of awareness of the intervention in both study arms
Month 12 Phase 12 census In all 24 study VDCs, collect the following data:
 ► Demographics/vital statistics update
 ► Ocular history screening (past 12 months)
 ► Symptom-based photography
Month 20 Intervention awareness survey In all 24 study VDCs, conduct a survey of a random sample of households to 
assess level of awareness of the intervention in both study arms
Month 24 Phase 24 census In all 24 study VDCs, collect the following data:
 ► Demographics/vital statistics update
 ► Ocular history screening past 12 months)
 ► Symptom-based photography
Month 32 Intervention awareness survey In all 24 study VDCs, conduct a survey of a random sample of households to 
assess level of awareness of the intervention in both study arms
Month 36 Phase 36 census (final) In all 24 study VDCs, collect the following data:
 ► Demographics/vital statistics update
 ► Ocular history screening (past 12 months)
 ► Bilateral photography of all participants
*Census photograph grading and the 12-month visit began after the month 12 census and continued on an ongoing basis.
FCHV, Female Community Health Volunteer; VDC, Village Development Committee.
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health projects, including family planning and immu-
nisation campaigns.33 34 Existing FCHVs in intervention 
VDCs are trained as part of the corneal ulcer prevention 
programme.
Training and supervision
FCHVs located in VDCs randomised to the intervention 
attend a 3-day training course at Bharatpur Eye Hospital. 
The initial training includes both lecture and hands-on 
practice. Lecture includes basic eye anatomy, common 
eye diseases and the difference between ocular trauma, 
corneal abrasion and corneal ulcer. FCHVs are trained 
to diagnose corneal abrasions using fluorescein strips, 
2.5x magnifying loupes and a light-emitting diode (LED) 
ultraviolet (UV) flashlight. FCHVs are also trained to 
measure counting fingers visual acuity, to administer eye 
ointments, and to enter data into study logbook forms.
Training is conducted in Nepali by trained study staff 
from the Bharatpur Eye Hospital and is supervised by 
the investigators. A quiz is administered at the end of 
the initial 3-day training. FCHVs with scores of 80% or 
greater are invited to begin intervention work immedi-
ately, whereas those with scores of <80% complete addi-
tional one-on-one training with the study staff. Illiterate 
FCHVs are asked to bring a family member or neighbour 
to the trainings to provide reading and writing support 
for the data entry portion of the programme.
The study team visits each FCHV weekly to review 
corneal abrasion cases, collect logbook data and 
replenish supplies. The study team conducts refresher 
trainings to review the basic concepts and skills required 
in diagnosing corneal abrasions. Brief refresher trainings 
are conducted monthly and more in-depth trainings are 
conducted every 6 months.
Corneal ulcer prevention programme
If a participant presents with ocular trauma, redness 
and/or pain and is interested in participating in the 
study, written consent is obtained before procedures are 
performed. If a participant is illiterate, thumbprints are 
obtained in the presence of a witness. Minors (partic-
ipants aged <18 years of age) and a parent or legal 
guardian both provide written consent. If the resident 
does not provide consent, the FCHV may still provide 
diagnosis and prophylaxis or referral, but she will not 
record any data onto the logbook form.
Any person presenting to the FCHV with ocular 
trauma, redness and/or pain is offered a corneal exam-
ination, which involves the application of fluorescein to 
the affected eye(s) and examination with 2.5x magnifying 
loupes and an LED UV flashlight to identify the presence of 
a corneal abrasion. Participants are immediately referred 
to Bharatpur Eye Hospital or the nearest primary eye care 
centre if they are diagnosed with a corneal ulcer, bilat-
eral corneal abrasions, visual acuity worse than counting 
fingers in the unaffected eye or some other ocular abnor-
mality that the FCHV cannot diagnose. Participants with 
a corneal abrasion receive nine single-dose applicaps of 
1% chloramphenicol ointment (Chloromycetin Kaps, 
Pfizer, India) and 1% itraconazole ointment (Itral, Jawa 
Pharmaceuticals) to be applied three times daily for 3 
days. Pregnant women are given 1% azithromycin oint-
ment (Zaha, Ajanta Pharma) instead of chloramphen-
icol. The FCHV applies the first dose to demonstrate the 
technique, and the remaining eight doses are performed 
by the participant without direct observation. The FCHV 
enters information about the participant into, including 
the participant’s demographic information and tele-
phone number, questions about risk factors for ocular 
trauma, date and time of presentation and of ocular 
trauma, visual acuity and follow-up visit status. After 3 
days, the participant is requested to return to the FCHV 
for a follow-up examination. At the follow-up visit, partic-
ipants report the number of doses of medication they 
used and answer an open-ended question about adverse 
events. Participants are asked to bring their used applicap 
containers and ointment tubes to the follow-up visit in 
order to corroborate reported adherence. The eye is 
re-examined with fluorescein using the same technique 
as before. If an allergic reaction, corneal abrasion or 
corneal ulcer is found on the follow-up examination, the 
participant is referred to Bharatpur Eye Hospital or the 
nearest primary eye care centre.
FCHVs will not refuse diagnosis or prophylaxis to 
anyone based on their residence, even if participants 
present from control VDCs. FCHVs will record the VDC 
of all people who present, which will allow us to assess the 
level of contamination.
Publicity
Study staff at Bharatpur Eye Hospital hold orientation 
meetings with teachers, traditional healers and local polit-
ical leaders to introduce the programme and to encourage 
community leaders to advertise the programmes. FCHVs 
in study communities advertise their services for ocular 
trauma through door-to-door visits with households in 
their wards and monthly meetings with their ward-level 
Mother’s Groups. FCHVs encourage the community to 
present to them within 24 hours of experiencing ocular 
trauma. FCHVs also post advertisements describing ulcer 
prevention throughout the community and distribute 
pamphlets, greeting cards and calendars describing the 
programme. All public publicity materials such as posters 
are removed prior to the annual census to maintain 
masking of the census workers. Publicity activities will be 




Demographics and screening questions. An annual census 
is conducted in all study communities over the 3-year 
study period. The baseline census was conducted before 
randomisation. Census workers visit each household in 
each study community. After obtaining verbal consent 
from the head of household, the census worker records 
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the full name, age and gender of each household 
member. The census worker also asks each household 
member several ocular history questions to determine 
which household members might have had a corneal 
ulcer. During interim census periods, the ocular history 
screening questions refer to experience of ocular symp-
toms within the past year; the first time the questions are 
asked, they refer to lifetime experience. The questions 
include experience of ocular trauma, sudden decreased 
vision, eye pain and corneal infection. Data are recorded 
using a custom-designed mobile application on Google 
Nexus 5 smartphones. Census workers use the mobile 
device to record the global positioning system (GPS) 
coordinates of every household to increase efficiency 
of follow-up activities and allow assessment of spatial 
relationships.
Corneal photographs. At the baseline and final census 
phases, the census workers photograph the corneas of 
all residents in the study area. During the interim census 
phases, the census workers photograph the corneas of 
those who answer one or more of the ocular screening 
questions affirmatively. A smartphone attachment, the 
Ocular CellScope (Development Impact Lab, Berkeley, 
California, USA), is used to improve the quality of 
corneal photographs.35 The CellScope is a three-dimen-
sional-printed device with a +25 Diopter lens and external 
illumination, which allows the smartphone camera to 
capture high-quality corneal photographs.
Training. Census workers attend a 3-day training at 
Bharatpur Eye Hospital prior to the start of each annual 
census. Training includes lectures, hands-on practice 
with the mobile application and photography and field 
practice in a non-study community. The study team moni-
tors each census worker weekly to confirm quality and 
completeness of data collection and photography. Data 
collection progress is monitored locally by study staff 
at Bharatpur Eye Hospital and by investigators at the 
University of California, San Francisco (UCSF) on  Sales-
force. com.
Photograph grading
Definitions. Photographs from individuals answering affir-
matively to any of the screening questions at a follow-up 
census are presented for grading in a random order. The 
grading programme presents all photos for a single eye 
at a time. Graders are masked to the grades and images 
of the contralateral eye, to study identifier and to other 
graders’ grades. After indicating whether all photographs 
were taken of the same eye, the photographs are graded 
for quality (good, poor but readable or unreadable), 
and then for the presence of an opacity (definitely yes, 
probably, possibly, definitely no). For any photograph 
graded as a possible, probable or definite opacity, the 
photographs from all preceding phases are presented for 
comparison. These previous photos are graded according 
to the same criteria. A random sample of photos stratified 
by the initial opacity grade is presented a second time to 
determine intrarater reliability.
Ophthalmologist adjudication. Photographs proceed 
through several rounds of grading. The process starts 
with two graders in Nepal independently grading all 
eligible corneal photographs. Photographs graded as 
possible, probable or definite opacity by either grader are 
then presented to one of three cornea specialists for a 
first round of adjudication. In addition, a random sample 
of photographs graded as definitely having no opacity or 
as unreadable quality are sent for the initial adjudication. 
Any photograph judged to be a possible, probable or defi-
nite opacity at this first level of adjudication, as well as 
any photographs graded as definitely no for opacity by 
the first adjudicator but probable or definite opacity by 
both of the initial graders, is subsequently sent to all three 
ophthalmologists for a second level of adjudication. If two 
of the three ophthalmologists grade an eye as having a 
probable or definite opacity at one phase, and definitely 
no opacity or a possible opacity at a previous phase, the 
eye will be classified as having an incident opacity for the 
primary outcome.
Training. Photograph graders and adjudicators receive 
extensive training. The training includes an overview of 
the anatomy of the cornea and the pathophysiology of 
corneal infections. During the training, each photograph 
grader is presented with 100 cornea photographs taken 
with the Ocular CellScope, half of which are of corneal 
ulcers or corneal scars, and half of which are of normal 
corneas. The results of this exercise are compared against 
an expert consensus reference grade, which was deter-
mined using the consensus grade from three ophthal-
mologists. Discrepancies are reviewed in person with 
the photograph graders. Graders who achieve a Cohen’s 
kappa >0.7 for inter-rater reliability (comparing the 100 
grades against the expert grader) are certified as graders. 
Graders are retrained and recertified each year, using a 
different set of corneal photographs.
Twelve-month nested case-control study
Design. A nested case-control study is conducted among 
incident cases of corneal ulcer and an equal number 
of age-matched (±2 years), sex-matched and commu-
nity-matched controls, with the visit scheduled to take 
place 12 months after the case’s symptoms started. Visits 
are preferably conducted at Bharatpur Eye Hospital, 
Kawasoti Eye Care Center or Parsa Eye Care Center; if 
participants cannot attend one of these facilities then a 
mobile team will visit the participant at their home. An 
eye examination is performed for each eye by an optom-
etrist or ophthalmic assistant, and risk factors for corneal 
ulceration and quality of life are assessed with stan-
dardised questionnaires. Study personnel conducting 
the 12‐month visit are masked to case-control status of 
the participant as well as randomisation arm during the 
procedures.
Clinical examination. Trained study personnel perform 
manifest refraction and best spectacle-corrected visual 
acuity assessments, followed by an eye examination and 
corneal photography. The eye examination is performed 
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with a slit lamp biomicroscope in the eye clinics, and 
with a penlight at the mobile examinations. Based on 
the eye examination, the examiner states the condition 
accounting for visual acuity worse than 20/20 (eg, corneal 
opacity, cataract, glaucoma, etc). In addition, the exam-
iner compares the vision in the worse-seeing eye with the 
better-seeing eye, and determines the ocular condition 
responsible for the decrement in the worse-seeing eye 
(eg, corneal opacity, cataract, glaucoma, etc).
Instruments. The Euroqol-5D‐5L Quality of Life 
Questionnaire and Hong Kong visual functioning ques-
tionnaires were translated from English to Nepali and 
back-translated independently by two bilingual study staff 
members at the Bharatpur Eye Hospital. A committee 
reviewed the questionnaires to determine the appropri-
ateness of the questions for this population and pilot-
tested the refined questionnaires on a sample of patients 
at the Bharatpur Eye Hospital. Questionnaires on risk 
factors for corneal ulcers include questions on agricul-
tural trauma, contact lens wear and use of topical cortico-
steroids, as well as healthcare seeking behaviours after eye 
trauma. The costing questionnaire elicits all patient-re-
lated and hospital-related costs of the corneal opacity, 
including laboratory testing, medications and surgeries, 
as well as the opportunity costs of attending hospital visits.
Clinic-based case finding
Clinic‐based case finding is conducted at several sites 
throughout the study area. These sites were identified as 
locations that receive corneal abrasion and corneal ulcer 
cases. Each month, study staff visit each of these sites 
and use the site’s patient logbook to record data on any 
corneal abrasion, corneal ulcer or corneal foreign body 
case that presented to that site in the past month.
Intervention awareness surveys
An intervention awareness survey is conducted annually 
in all VDCs, with survey workers not informed about the 
trial intervention, and masked to whether the commu-
nity has been randomised to intervention or control. 
A random sample of households from the most recent 
census is selected to participate in the survey. Census 
data, including name, phone number and household 
GPS coordinates, are uploaded to the mobile software 
platform GIS Cloud (GIS Cloud, London, UK, http://
www. giscloud. com) for the survey. The trained survey 
workers use handheld mobile devices to identify house-
holds from a map generated by the application, and ask 
an adult in the household a series of questions designed 
to determine their level of awareness of the intervention. 
Survey workers are required to complete the survey on at 
least 10 of the 15 selected households in each ward.
Conducting the intervention awareness surveys in 
control VDCs will provide a measure of contamination. 
Publicity is limited to intervention VDCs to reduce the like-
lihood of contamination, but it is possible that residents 
of control VDCs will learn of the intervention through 
exposure to publicity materials or word of mouth. Any 
awareness of the intervention found in control VDCs will 
be indicative of contamination.
An unmasked intervention awareness survey is 
conducted by trained study personnel annually in inter-
vention VDCs only. Unlike the masked survey, survey 
workers understand the nature of the intervention and 
publicity campaign, and provide additional information 
about the programme if the resident is unaware of the 
intervention. The unmasked survey is conducted identi-
cally to the masked survey in terms of selection of house-
holds and data collection and management, but provides 
information about the impact of the intervention sooner, 
so that corrective actions can be taken.
Programmatic costs
All programmatic costs, including staff salaries, equip-
ment, antimicrobial ointments, outreach and advertising 
and training costs are recorded by the study coordinator 
during the trial. Costs are collected by the study coordi-
nator for each year of the programme.
data collection, management, monitoring
All electronic data and photographs are uploaded daily to 
secure, cloud-based servers. Data collected on paper are 
double-data entered and adjudicated in REDCap.36 Study 
personnel collecting data receive at least a 1 day initial 
training, and periodic refresher trainings. Study staff 
at Bharatpur Eye Hospital conduct weekly monitoring 
visits to all FCHVs, census workers and survey workers 
collecting data, and data collection progress is reviewed 
by the data manager at UCSF weekly.
data and safety Monitoring Committee
The Data and Safety Monitoring Committee (DSMC) 
for this trial includes independent experts in bioethics, 
biostatistics, epidemiology, ophthalmology and inter-
national public health appointed by the National Eye 
Institute-National Institutes of Health and empaneled 
before the start of the study. The DSMC meets at least 
once each year, and organises teleconferences as needed 
for progress reporting. The study protocol and modi-
fications are subject to review and approval by Insti-
tutional Review Boards at UCSF and in Nepal, and by 
the DSMC. The DSMC monitors severe or unexpected 
events that threaten the safety of patients and oversees 
the data collected throughout the duration of the study. 
The DSMC is responsible for reviewing the results of the 
interim analysis and determining whether or not the trial 
should continue, with or without modifications.
statistical analysis plan
Sample size
Sample size and power calculations are based on an esti-
mated incidence of corneal ulceration of 100 per 100 000 
person-years. We estimate that 12 VDCs per arm will 
provide >80% power to detect a 30% reduction in inci-
dence of corneal ulceration, assuming 9000 people per 
VDC, an intraclass correlation coefficient of 0.00015 and 
a two-tailed alpha of 0.05.
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Interim analysis and stopping guidelines
An interim analysis for efficacy is performed one-third 
of the way through the trial, with alpha set at 0.001. The 
interim analysis has approximately 70% power to detect a 
68% reduction in corneal ulcer rates over the single year. 
The DSMC reviews the unmasked interim analysis and 
makes recommendations on the continuation of the trial. 
No interim analysis for futility is performed.
Specific aim 1
The primary analysis is negative binomial regression to 
compare the incidence of corneal ulcers between treat-
ment arms, with the count of incident corneal ulcers over 
the study period as the outcome, log person-time at risk as 
an offset and treatment arm as the sole covariate. An indi-
vidual is determined to have an ulcer if a new opacity is 
identified by photograph grading at a follow-up census. For 
individual-level data, an opacity identified at a follow-up 
census will be considered new if it is absent on a photo-
graph of acceptable quality from at least one previous 
census. For community-level data, we will compute the 
total count of new opacities identified in each randomis-
ation unit at each of the follow-up census phase. Individ-
uals can contribute multiple incident ulcers to the overall 
count, but no more than one new opacity per eye per 
phase. Individuals start contributing person-time at the 
first census they are photographed and continue contrib-
uting person-time until the final census with complete 
data (ie, screening questions answered, and if required, 
then photographs taken and uploaded). Individuals who 
develop ulcers will continue to contribute person time 
and can contribute additional ulcers until they leave the 
study (ie, permanently moved, died or study conclusion).
Negative binomial regression explicitly addresses 
the cluster-randomised nature of the design, and the 
proposed analysis follows the intent-to-treat principle. We 
will use a permutation p value, taking into account the 
stratified design of the randomisation.
Specific aim 2
The primary analysis is a trial-based cost-effectiveness anal-
ysis of the costs per corneal ulcer prevented, assessed at 
the VDC level. Costs include all programmatic and treat-
ment costs per VDC over the duration of the 3-year study. 
The effectiveness outcome will be the same as for specific 
aim 1: the number of incident corneal opacities per VDC. 
Both costs and effects will be discounted at 5% per year 
for the 3-year time horizon of the analysis. We will use the 
non-parametric bootstrap to estimate the joint sampling 
distribution of the differences in average VDC costs and 
effects between the treatment arms, and plot this on 
the cost-effectiveness plane and in a cost-effectiveness 
Table 2 Trial registration data and protocol summary
Data category Information
Primary registry and trial identifying number ClinicalTrials.gov NCT01969786
Date of registration in primary registry 25 October 2013
Secondary identifying numbers U10EY022880
Source(s) of monetary or material support National Eye Institute-National Institutes of Health
Primary sponsor National Eye Institute-National Institutes of Health
Secondary sponsor(s)
Contact for queries Thomas M Lietman, MD (tom.lietman@ucsf.edu)
Title Village Integrated Eye Worker trial
Countries of recruitment Nepal
Health condition(s) or problem(s) studied Corneal ulcer prevention
Intervention(s) Intervention: training volunteer community health workers to diagnose corneal 
abrasions and provide antimicrobial ointment to prevent corneal ulcers
Control: no intervention
Key eligibility criteria Community-level eligibility criteria (Village Development Committee): 
located within the catchment area of Bharatpur Eye Hospital, 
Population≥15 000 according to the 2001 national census
Individual-level eligibility criteria: resident of eligible Village Development 
Committee
Study type Cluster-randomised trial
Date of first enrolment January 2014
Target sample size 24 Village Development Committees, 216 000 individuals
Recruitment status Recruiting
Primary outcome(s) Incidence of corneal ulcer (time frame: 3 years)
Key secondary outcomes Trial-based cost-effectiveness analysis
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acceptability curve. In a secondary analysis, we convert 
visual acuity data from the 12-month visit into quality-ad-
justed life-years (QALYs), and perform the same analyses 
in terms of costs per QALYs lost. We will also conduct 
a hypothetical cohort-based cost-effectiveness analysis 
as a supplement to assist in interpretive generalisation 
beyond the specific programmatic cost structure of the 
Nepal trial setting.
Specific aim 3
The primary analysis is an assessment of the true inci-
dence of corneal ulceration in the control arm. The 
primary outcome of the trial (specific aim 1) will produce 
an estimate of the incidence of corneal ulceration suffi-
cient to answer the overall research question, but the 
estimate itself may be biased by outcome misclassification 
and missing data. The use of census photographs alone as 
the outcome will result in some number of false negatives 
and false positives. Despite rigorous efforts to ensure high 
coverage during census phases, it is not possible to capture 
every single person, thus it is possible to miss incident 
ulcers using only census photographs as the outcome. In 
addition, the grading process inevitably results in some 
photos falsely classified as having an opacity. Internal 
validation data collected during the 12-month nested 
case-control study will be used to correct the estimate of 
the incidence in the control arm for misclassification.
We will report community-stratified, age-stratified and 
gender-stratified incidence rates. The spatial distribution 
of incident corneal ulcers will be examined using coordi-
nates obtained at the time of the census. The association 
between incident corneal ulceration and individual-level 
risk factors collected at the time of the census, including 
age, sex and urban/rural residence, will be assessed with 
clustered logistic regression.
Patient and public involvement
Focus groups were conducted among residents of 
randomly selected communities within the study area to 
identify local eye health resource utilisation patterns and 
understand the language used to describe ocular trauma. 
Summaries of focus group discussions are used to inform 
training programmes for census workers, intervention 
awareness survey workers and publicity campaigns. 
Feedback from FCHVs participating in the training 
programme is used to improve refresher trainings.
Ethics and dissemination
The District Public Health Offices of the Nawalparasi and 
Chitwan districts provide approval for the study each year 
before census data collection commences. The trial is 
registered at  clinicaltrials. gov (NCT01969786). Protocol 
modifications are submitted to the relevant parties for 
review and/or approval. Table 2 summarises the study 
protocol and trial registration information.
Verbal consent is obtained for census and photog-
raphy, awareness surveys and the 12-month follow-up 
visit. Written consent is obtained for FCHV-administered 
medications. Data and photos collected on individuals 
are linked to individual participant information using 
unique identifiers. Only key study personnel have access 
to identifying information.
The results of this trial will be presented at local and 
international meetings and submitted to peer-reviewed 
journals for publication.
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